Drug Topics e-News:

Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Subscribe Now

to Drug Topics e-News

Drug Topics, Voice of the Pharmacist
Part of the Modern Medicine Network

e-News

DrugTopics.com

June 23, 2011

Drug Topics
Home CE DT Blog JP at Large Viewpoints Regulatory and Legal Archives
In This Issue
Actos linked to bladder cancer
Anticoagulation update
Victoza associated with thyroid cancer
Risperidone, ropinirole mix-ups
Merck redesigns drug labels
Syringe labeling device decreases errors
Continuing Education
Newest: Osteoporosis update
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here
Meetings
Survey
This month we would like to know...
To reduce 30-day readmission rates for Medicare beneficiaries, our health system:

• Uses pharmacists' medication therapy management skills in hospital-to-home transitions

• Plans to use pharmacists' medication therapy management skills in hospital-to-home transitions within 6 months

• Plans to use pharmacists' medication therapy management skills in hospital-to-home transitions within 12 months

• Has no plans in place to use pharmacists' medication therapy management skills in hospital-to-home transitions

Click Here to Vote

Digital Edition

Drug Topics Digital Edition View Current Edition Subscribe to the Digital Edition

Longer-term use of pioglitazone associated with an increased risk
of bladder cancer

FDA published an online safety communication on June 15, informing prescribers and patients that pioglitazone (Actos, Takeda Pharmaceuticals America Inc., Deerfield, Illinois) use may be associated with a 20% to 40% increased hazard of new bladder cancer. Read full article.

divider

Anticoagulation update

Leeann Hakobyan

A monthly review of the
peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS.
Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.

Risk of recurrent VTE higher in men. Read full article.

divider

Victoza's association with thyroid cancer emphasized in Novo Nordisk reminder

Novo Nordisk recently sent a letter to healthcare professionals, reminding them about the potential risks of thyroid C-Cell tumors and acute pancreatitis associated with Victoza. Read full article.

divider

FDA alerts pharmacists to risperidone, ropinirole mix-ups

FDA announced reports of medication errors involving risperidone (Risperdal, Johnson & Johnson) and ropinirole (Requip, GlaxoSmithKline), noting that in some cases, patients who took the wrong medication needed to be hospitalized, according to a Medication Safety Announcement released June 13. Read full article.

divider

Merck redesigns drug labels
to prevent dispensing errors

Merck & Co. has redesigned 34 of its drug container labels to improve readability and provide better information on product and strength differentiation, according to a statement on the company's website. Read full article.

divider

Syringe labeling device improves patient safety, decreases medical errors

A new labeling system improves the syringe preparation workflow by automatically printing full-color labels compliant with American Society of Anesthesiologists and containing all The Joint Commission required elements, announced a statement issued by the manufacturer. Read full article.

divider

Meetings and Events

June 25-28, 2011 NACDS Marketplace Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
registration@nacds.org

July 22-25, 2011 NPhA Annual Convention
Atlanta
Contact:
107 Kilmayne Drive, Suite C
Cary, NC 27511
Phone: 404-262-3344
Fax: 404-262-8689

August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

October 6-7 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447

CEC

Connect to Us

Twitter Follow Us on Twitter
Contact Us Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Medical Communications Group

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.